| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |